MARKER THERAPEUTICS, INC. Interest Receivable
MARKER THERAPEUTICS, INC. (MRKR) had Interest Receivable of $559 as of 2020-12-31, per its 10-K filed 2021-03-09.
Discontinued › Balance Sheet › Assets
us-gaap:InterestReceivable · last filed 2021-03-09
- 2020-12-31: Interest Receivable $559.00.
- 2020-09-30: Interest Receivable $135.00.
- 2020-06-30: Interest Receivable $3.44K.
- 2020-03-31: Interest Receivable $24.61K.
| Period end | Interest Receivable |
|---|---|
| 2020-12-31 | $559.00 10-K · filed 2021-03-09 |
| 2020-09-30 | $135.00 10-Q · filed 2020-11-09 |
| 2020-06-30 | $3.44K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $24.61K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $56.19K 10-K · filed 2021-03-09 |
| 2019-09-30 | $78.14K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $98.15K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $112.20K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $108.18K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |